Volume 18, Number 6—June 2012
CME ACTIVITY
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
Frédéric Bert
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
, Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-ChanoineTable 1
Characteristics of 710 liver transplant recipients included in study of ESBLE pretransplant fecal carriage and posttransplant infection, France, January 2001–April 2010*
| Characteristic | Value |
|---|---|
| Age, y, mean ± SD | 50 ± 11 |
| Male sex | 490 (69) |
| Viral hepatitis | 261 (36.7) |
| Hepatocellular carcinoma | 221 (31.1) |
| Alcoholism | 196 (27.6) |
| Acute liver failure | 74 (10.4) |
| Biliary disease | 61 (8.6) |
| HIV infection | 21 (3) |
| MELD score, mean ± SD | 18 ± 9 |
*Values are no. (%) patients except as indicated. ESBLE, extended spectrum β-lactamase–producing Enterobacteriaceae; MELD, Model for End-stage Liver Disease.
